Hepatitis C virus seroconversion and genotype prevalence in patients and staff on chronic hemodialysis

Journal of Clinical Gastroenterology

Volumn 28, Issue 1, 1999, Pages 23-28

  Zamir, Doron ^a   Storch, Shimon ^a   Zonder, Hilkiahu B ^a   Zamir, Chen ^b   Weiner, Paltiel ^a  

^a HILLEL YAFFE MEDICAL CENTER   (Israel)

^b Hadera Subdistrict Health Office   (Israel)

Author keywords

Coexistence of genotypes; Hemodialysis; Hepatitis C genotypes; Seroconversion

Indexed keywords

AMINOTRANSFERASE; VIRUS RNA;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROCONVERSION; VIRUS ISOLATION;

ANTIBODIES, VIRAL; BLOOD TRANSFUSION; CROSS INFECTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEMODIALYSIS UNITS, HOSPITAL; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; PATIENT ISOLATION; RENAL DIALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES;

EID: 0032941214     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199901000-00005     Document Type: Article

References (35)

1. Mortimer PP, Cohen BJ, Litton PA, et al. Hepatitis C virus antibody. Lancet 1989;2:798.
2. Roggendorf M, Dienhardt F, Rasshofer R, et al. Antibodies to hepatitis C virus. Lancet 1989;2:324-325.
3. Oesterreicher C, Hammer J, Koch U, et al. HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. Kidney Int 1995;48:1967-1971.
4. Golan E, Korzets Z, Cristal-Lilov A, et al. Increased prevalence of HCV antibodies in dialyzed Ashkenazi Jews - a possible ethnic predisposition. Nephrol Dialysis Transplant 1996;11:684-686.
5. Fujiyama S, Kawano S, Sato S. et al. Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff. Hepatogastroenterology 1995;42:162-165.
6. Cendoroglo-Neto M, Manzano SI, Canziani ME, et al. Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit. Artif Organs 1995;19:251-255.
7. Huraib S, Al Rashed R, Aldrees A, et al. High prevalence and risk factors for hepatitis C in hemodialysis patients in Saudi Arabia. Nephrol Dial Transplant 1995;10:470-474.
8. El-Gohary A, Hassan A, Nooman Z, et al. High prevalence of hepatitis C virus among urban and rural population groups in Egypt. Acta Trop 1995;59:155-161.
9. Kohler H. The prevalence of hepatitis C in different countries of the ERA-EDTA area. Nephrol Dial Transplant 1995;10:468-469.
10. Szmuness W, Prince AM, Grady GF, et al. Hepatitis B infection: a point prevalence in study of 15 US hemodialysis centers. JAMA 1974;227:901-904.
11. Martino-Peignoux M, Marcellin P, Pouteau M. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to Interferon therapy in chronic hepatitis. Hepatology 1995;22:1050-1056.
12. Lee WM with the Hepatitis Study Group. Does hepatitis C viral (HCV) genotype of HCV-RNA titer predict induction of response to interferon alfa 1a in chronic hepatitis C [abstract and oral presentation]. Hepatology 1995;22:176A.
13. El-Zayidi A, Selin O, Elhadad S. Combination treatment of alpha interferon 2b and ribavarin in chronic hepatitis C genotype 4 patients resistant to interferon therapy [abstract and oral presentation]. Hepatology 1995;22:415A.
14. Smalcelj R. Slavicek J, Glavas-Boras S, et al. Prevention of hepatitis C infection in hemodialysis unit [letter]. Nephrol Dial Transplant 1995;10:14:73-74.
15. Beccari M. Treatment options for HCV-positive hemodialysis patients [letter]. Nephrol Dial Transplant 1995;10:1474-1475.
16. Yussa T, Ishikawa G, Manaba S, et al. The particle size of hepatitis C virus estimated by filtration through microporus regenerated cellulose fiber. J Gen Virol 1991;72:2021-2024.
17. Boero R, Martina G, Boszo P, et al. HCV viremia in hemodialysis patients: detection by a DNA enzyme immunoassay for amplified HCV sequences. Ren Fail 1995;17:565-573.
18. Chiaramont S. Tagger A, Ribero Mlet, et al. Prevention of viral hepatitis in dialysis units: isolation and technical management of dialysis. Nephron 1992;61:287-289.
19. Aucella F, Martini E, Centra M, et al. Epidemiology of hepatitis C virus infection in hemodialysis (a study of the gargano area). Recenti Prog Med 1995;86:332-335.
20. Fabrizi F, Lunghi G, Guarnori I, et al. Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: a cross sectional study. Clin Nephrol 1995;44:49-55.
21. Pereira BJ, Levey AS. Hepatitis C virus infection in dialysis and transplantation. Kidney Int 1997;51:981-999.
22. Jadoul M, Cornu C, Van Aypersele de Striheu C, et al. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. Kidney Int 1993;43:1322-1326.
23. Gilli P, Soffritti S, De-Paoli-Vitali E, Bedani PL. Prevention of hepatitis C virus in dialysis units. Nephron 1995;70:301-306.
24. Medin C, Allander T, Roll M, Jacobson SH, Grillner L. Seroconversion to hepatitis C virus in dialysis patients: a retrospective and prospective study. Nephron 1993;65:40-45.
25. Colombo P, Filiberti O, Porcu M, et al. Prevalence of hepatitis C infection in a hemodialysis unit. Nephron 1992;61:326-327.
26. Vasile A, Allegra V, Canciani D, Forchi G, Mengozzi G. Prospective and retrospective assessment of clinical and laboratory parameters in maintenance hemodialysis patients with and without HCV antibodies. Nephron 1992;61:318-319.
27. Bouchardeau T, Chauveau P, Courouce AM, Poignet JL. Genotype distribution of hepatitis C virus in French hemodialysis patients. Nephrol Dialysis Transplant 1995;10:2250-2252.
28. Widell A, Shev S, Mansson S, et al. Genotyping of hepatitis C isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applications. J Med Virol 1994;44: 272-229.
29. Corcoran GD, Brink NS, Miller CG, et al. Hepatitis C virus infection in haemodialysis patients: a clinical and virological study. J Infect 1994;28:279-285.
30. Wu JS, Lee HF, Hsiau HL, et al. Genotype distribution of hepatitis C virus infection in Taiwan. J Med Virol 1994;44:74-79.
31. Hadiwandowo S, Tsuda F, Okamoto H. et al. Hepatitis B virus subtypes and hepatitis C virus genotypes in patients with chronic liver disease or on maintenance hemodialysis in Indonesia. J Med Virol 1994;43:182-186.
32. Bogomolsky-Yahalom V, Ashur Y, Klein A, Tur-Kaspa R. Hepatitis C virus genotypes in patients with persistent infection - a preliminary report. Isr J Med Sci 1997;33:18-22.
33. Pol D, Taiers V, Nousbaum JB, et al. The Changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. Gastroenterology 1995;100:591-593.
34. Sheng L, Willems M, Peerlinck K. Hepatitis C virus genotypes in belgian hemophiliacs. J Med Virol 1995;45:211-214.
35. Okuno H, Zie ZC, Lu BY, et al. Genotypes of hepatitis C virus in Guangxi Province, Southern China. J Gastroenterol Hepatol 1994;9:169-171.